Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal Cancer.

Gurjao C, Liu D, Hofree M, AlDubayan SH, Wakiro I, Su MJ, Felt K, Gjini E, Brais LK, Rotem A, Rosenthal MH, Rozenblatt-Rosen O, Rodig S, Ng K, Van Allen EM, Corsello SM, Ogino S, Regev A, Nowak JA, Giannakis M.

Cancer Immunol Res. 2019 Aug;7(8):1230-1236. doi: 10.1158/2326-6066.CIR-18-0683. Epub 2019 Jun 19.

PMID:
31217164
2.

Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' Disease.

Paragliola RM, Di Donna V, Locantore P, Papi G, Pontecorvi A, Corsello SM.

Front Endocrinol (Lausanne). 2019 Mar 1;10:95. doi: 10.3389/fendo.2019.00095. eCollection 2019.

3.

Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art.

Paragliola RM, Torino F, Papi G, Locantore P, Pontecorvi A, Corsello SM.

Eur Endocrinol. 2018 Sep;14(2):62-66. doi: 10.17925/EE.2018.14.2.62. Epub 2018 Sep 10. Review.

4.

Medullary Thyroid Carcinoma With Exon 2 p.L56M RET Variant: Clinical Particular Features in Two Patients.

Paragliola RM, Lovicu RM, Papi G, Capoluongo E, Minucci A, Canu G, Pontecorvi A, Corsello SM.

Front Endocrinol (Lausanne). 2018 Jul 19;9:398. doi: 10.3389/fendo.2018.00398. eCollection 2018.

5.

46,XY Disorder of Sex Development Caused by 17α-Hydroxylase/17,20-Lyase Deficiency due to Homozygous Mutation of CYP17A1 Gene: Consequences of Late Diagnosis.

Papi G, Paragliola RM, Concolino P, Di Donato C, Pontecorvi A, Corsello SM.

Case Rep Endocrinol. 2018 Apr 24;2018:2086861. doi: 10.1155/2018/2086861. eCollection 2018.

6.

Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS).

Rochira V, Mossetto G, Jia N, Cannavo S, Beck-Peccoz P, Aimaretti G, Ambrosio MR, Di Somma C, Losa M, Ferone D, Lubrano C, Scaroni C, Giampietro A, Corsello SM, Poggi M.

J Endocrinol Invest. 2018 Nov;41(11):1259-1266. doi: 10.1007/s40618-018-0860-x. Epub 2018 Mar 13.

7.

A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.

Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, Gould J, Davis JF, Tubelli AA, Asiedu JK, Lahr DL, Hirschman JE, Liu Z, Donahue M, Julian B, Khan M, Wadden D, Smith IC, Lam D, Liberzon A, Toder C, Bagul M, Orzechowski M, Enache OM, Piccioni F, Johnson SA, Lyons NJ, Berger AH, Shamji AF, Brooks AN, Vrcic A, Flynn C, Rosains J, Takeda DY, Hu R, Davison D, Lamb J, Ardlie K, Hogstrom L, Greenside P, Gray NS, Clemons PA, Silver S, Wu X, Zhao WN, Read-Button W, Wu X, Haggarty SJ, Ronco LV, Boehm JS, Schreiber SL, Doench JG, Bittker JA, Root DE, Wong B, Golub TR.

Cell. 2017 Nov 30;171(6):1437-1452.e17. doi: 10.1016/j.cell.2017.10.049.

8.

Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis.

Paragliola RM, Papi G, Pontecorvi A, Corsello SM.

Int J Mol Sci. 2017 Oct 20;18(10). pii: E2201. doi: 10.3390/ijms18102201. Review.

9.

Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment.

Paragliola RM, Corsello SM.

Minerva Endocrinol. 2018 Jun;43(2):183-197. doi: 10.23736/S0391-1977.17.02701-8. Epub 2017 Jul 27. Review.

10.

Is levothyroxine requirement the same for tablet and soft gel formulations?

Di Donna V, Paragliola RM, de Waure C, Papi G, Pontecorvi A, Corsello SM.

Endocrine. 2018 Feb;59(2):458-460. doi: 10.1007/s12020-017-1311-8. Epub 2017 May 2. No abstract available.

PMID:
28466401
11.

The Drug Repurposing Hub: a next-generation drug library and information resource.

Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, Johnston SE, Vrcic A, Wong B, Khan M, Asiedu J, Narayan R, Mader CC, Subramanian A, Golub TR.

Nat Med. 2017 Apr 7;23(4):405-408. doi: 10.1038/nm.4306. No abstract available.

12.

Current best practice in the management of patients after pituitary surgery.

Prete A, Corsello SM, Salvatori R.

Ther Adv Endocrinol Metab. 2017 Mar;8(3):33-48. doi: 10.1177/2042018816687240. Epub 2017 Mar 1. Review.

13.

Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.

Ghazani AA, Oliver NM, St Pierre JP, Garofalo A, Rainville IR, Hiller E, Treacy DJ, Rojas-Rudilla V, Wood S, Bair E, Parello M, Huang F, Giannakis M, Wilson FH, Stover EH, Corsello SM, Nguyen T, Rana HQ, Church AJ, Lowenstein C, Cibulskis C, Amin-Mansour A, Heng J, Brais L, Santos A, Bauer P, Waldron A, Lo P, Gorman M, Lydon CA, Welch M, McNamara P, Gabriel S, Sholl LM, Lindeman NI, Garber JE, Joffe S, Van Allen EM, Gray SW, Ja Nne PA, Garraway LA, Wagle N.

Genet Med. 2017 Jul;19(7):787-795. doi: 10.1038/gim.2016.191. Epub 2017 Jan 26.

PMID:
28125075
14.

Differential diagnosis of pituitary masses at magnetic resonance imaging.

Corsello SM, Paragliola RM.

Endocrine. 2017 Oct;58(1):1-2. doi: 10.1007/s12020-017-1230-8. Epub 2017 Jan 16. No abstract available.

PMID:
28092068
15.

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors.

Paragliola RM, Prete A, Papi G, Torino F, Corsello A, Pontecorvi A, Corsello SM.

Drug Des Devel Ther. 2016 Oct 25;10:3459-3470. eCollection 2016. Review.

16.

Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance.

Paragliola RM, Corsello SM, Salvatori R.

Pituitary. 2017 Feb;20(1):109-115. doi: 10.1007/s11102-016-0768-4. Review.

PMID:
27778296
17.

A Rare Case of Lateral Ectopic Thyroid.

Paragliola RM, Papi G, Lovicu RM, Pontecorvi A, Corsello SM.

Clin Nucl Med. 2016 Dec;41(12):936-937.

PMID:
27749423
18.

Mouse models of medullary thyroid cancer and developing new targeted therapies.

Paragliola RM, Torino F, Papi G, Locantore P, Pontecorvi A, Corsello SM.

Expert Opin Drug Discov. 2016 Oct;11(10):917-9. doi: 10.1080/17460441.2016.1223036. Epub 2016 Aug 19. No abstract available.

PMID:
27541085
19.

Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.

Prete A, Paragliola RM, Bottiglieri F, Rota CA, Pontecorvi A, Salvatori R, Corsello SM.

Endocrine. 2017 Mar;55(3):969-980. doi: 10.1007/s12020-016-1007-5. Epub 2016 Jul 9.

PMID:
27395418
20.

Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles.

Kim E, Ilic N, Shrestha Y, Zou L, Kamburov A, Zhu C, Yang X, Lubonja R, Tran N, Nguyen C, Lawrence MS, Piccioni F, Bagul M, Doench JG, Chouinard CR, Wu X, Hogstrom L, Natoli T, Tamayo P, Horn H, Corsello SM, Lage K, Root DE, Subramanian A, Golub TR, Getz G, Boehm JS, Hahn WC.

Cancer Discov. 2016 Jul;6(7):714-26. doi: 10.1158/2159-8290.CD-16-0160. Epub 2016 May 4.

21.

Endocrinological side-effects of immune checkpoint inhibitors.

Torino F, Corsello SM, Salvatori R.

Curr Opin Oncol. 2016 Jul;28(4):278-87. doi: 10.1097/CCO.0000000000000293. Review.

PMID:
27136136
22.

MANAGEMENT OF CATECHOLAMINE-SECRETING TUMORS IN PREGNANCY: A REVIEW.

Prete A, Paragliola RM, Salvatori R, Corsello SM.

Endocr Pract. 2016 Mar;22(3):357-70. doi: 10.4158/EP151009.RA. Epub 2015 Nov 4. Review.

PMID:
26536138
23.

A meta-analysis-derived proposal for a clinical, ultrasonographic, and cytological scoring system to evaluate thyroid nodules: the "CUT" score.

Ianni F, Campanella P, Rota CA, Prete A, Castellino L, Pontecorvi A, Corsello SM.

Endocrine. 2016 May;52(2):313-21. doi: 10.1007/s12020-015-0785-5. Epub 2015 Oct 30.

PMID:
26518189
24.

Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram.

Barnabei A, Strigari L, Marchetti P, Sini V, De Vecchis L, Corsello SM, Torino F.

Oncologist. 2015 Oct;20(10):1111-8. doi: 10.1634/theoncologist.2015-0183. Epub 2015 Sep 4.

25.

Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry.

Losa M, Beck-Peccoz P, Aimaretti G, Di Somma C, Ambrosio MR, Ferone D, Giampietro A, Corsello SM, Poggi M, Scaroni C, Jia N, Mossetto G, Cannavò S, Rochira V.

Clin Endocrinol (Oxf). 2015 Oct;83(4):527-35. doi: 10.1111/cen.12839. Epub 2015 Jul 31.

PMID:
26119712
26.

A rare case of juvenile hypertension: coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism.

Paragliola RM, Capoluongo E, Torino F, Minucci A, Canu G, Prete A, Pontecorvi A, Corsello SM.

BMC Endocr Disord. 2015 Jun 18;15:30. doi: 10.1186/s12902-015-0022-5.

27.

Iodine Supplementation: Usage "with a Grain of Salt".

Prete A, Paragliola RM, Corsello SM.

Int J Endocrinol. 2015;2015:312305. doi: 10.1155/2015/312305. Epub 2015 Mar 19. Review.

28.

A functional landscape of resistance to ALK inhibition in lung cancer.

Wilson FH, Johannessen CM, Piccioni F, Tamayo P, Kim JW, Van Allen EM, Corsello SM, Capelletti M, Calles A, Butaney M, Sharifnia T, Gabriel SB, Mesirov JP, Hahn WC, Engelman JA, Meyerson M, Root DE, Jänne PA, Garraway LA.

Cancer Cell. 2015 Mar 9;27(3):397-408. doi: 10.1016/j.ccell.2015.02.005.

29.

Parathyroid gland involvement by thyroid cancer: results from a large series of thyroidectomies performed in two italian university hospitals and review of the literature.

Papi G, Corrado S, Fadda G, Maiorana A, Maccio L, Corsello SM, Pontecorvi A.

J Thyroid Res. 2014;2014:685425. doi: 10.1155/2014/685425. Epub 2014 Nov 11.

30.

The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

Isidori AM, Graziadio C, Paragliola RM, Cozzolino A, Ambrogio AG, Colao A, Corsello SM, Pivonello R; ABC Study Group.

J Hypertens. 2015 Jan;33(1):44-60. doi: 10.1097/HJH.0000000000000415. Review.

31.

Pediatric Cushing's Disease and Pituitary Incidentaloma: Is This a Real Challenge?

Paragliola RM, Locantore P, Pontecorvi A, Corsello SM.

Case Rep Endocrinol. 2014;2014:851942. doi: 10.1155/2014/851942. Epub 2014 Oct 20.

32.

Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature.

Appetecchia M, Barnabei A, Pompeo V, Sentinelli S, Baldelli R, Corsello SM, Torino F.

BMC Endocr Disord. 2014 Oct 11;14:84. doi: 10.1186/1472-6823-14-84. Review.

33.

A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease.

Di Donna V, Santoro MG, de Waure C, Ricciato MP, Paragliola RM, Pontecorvi A, Corsello SM.

Thyroid. 2014 Dec;24(12):1759-64. doi: 10.1089/thy.2014.0111.

PMID:
25268754
34.

Clinical concepts on thyroid emergencies.

Papi G, Corsello SM, Pontecorvi A.

Front Endocrinol (Lausanne). 2014 Jul 1;5:102. doi: 10.3389/fendo.2014.00102. eCollection 2014. Review.

35.

Treatment of hypopituitarism in patients receiving antiepileptic drugs.

Paragliola RM, Prete A, Kaplan PW, Corsello SM, Salvatori R.

Lancet Diabetes Endocrinol. 2015 Feb;3(2):132-40. doi: 10.1016/S2213-8587(14)70081-6. Epub 2014 Jun 2. Review.

PMID:
24898833
36.

Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy.

Savino G, Mandarà E, Gari M, Battendieri R, Corsello SM, Pontecorvi A.

Endocrine. 2015 Feb;48(1):241-7. doi: 10.1007/s12020-014-0283-1. Epub 2014 Jun 1.

PMID:
24880619
37.

The impact of Graves' disease and its treatment on handwriting characteristics.

Papi G, Botti C, Corsello SM, Ciardullo AV, Pontecorvi A, Hegedüs L.

Thyroid. 2014 Aug;24(8):1218-22. doi: 10.1089/thy.2013.0668. Epub 2014 May 9.

PMID:
24694270
38.

The role of adrenal scintigraphy in the diagnosis of subclinical Cushing's syndrome and the prediction of post-surgical hypoadrenalism.

Ricciato MP, Di Donna V, Perotti G, Pontecorvi A, Bellantone R, Corsello SM.

World J Surg. 2014 Jun;38(6):1328-35. doi: 10.1007/s00268-014-2482-6.

PMID:
24615601
39.

Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.

Baldelli R, Barnabei A, Rizza L, Isidori AM, Rota F, Di Giacinto P, Paoloni A, Torino F, Corsello SM, Lenzi A, Appetecchia M.

Front Endocrinol (Lausanne). 2014 Feb 7;5:7. doi: 10.3389/fendo.2014.00007. eCollection 2014. Review.

40.

Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis.

Campanella P, Ianni F, Rota CA, Corsello SM, Pontecorvi A.

Eur J Endocrinol. 2014 Apr 10;170(5):R203-11. doi: 10.1530/EJE-13-0995. Print 2014 May. Review.

PMID:
24536085
41.

Cushing's syndrome due to a bronchial ACTH-secreting carcinoid successfully treated with radiofrequency ablation (RFA).

Corsello SM, Senes P, Iezzi R, Rufini V, Congedo MT, Paragliola RM, Pontecorvi A.

J Clin Endocrinol Metab. 2014 May;99(5):E862-5. doi: 10.1210/jc.2013-4359. Epub 2014 Jan 31.

PMID:
24483161
42.

Papillary thyroid carcinoma with predominant spindle cell component: report of two rare cases and discussion on the differential diagnosis with other spindled thyroid neoplasm.

Corrado S, Corsello SM, Maiorana A, Rossi ED, Pontecorvi A, Fadda G, Papi G.

Endocr Pathol. 2014 Sep;25(3):307-14. doi: 10.1007/s12022-013-9290-7.

PMID:
24356783
43.

"Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging.

Paragliola RM, Torino F, Senes P, Castellino L, Salutari V, Pontecorvi A, Scambia G, Corsello SM.

Endocrine. 2014 Jun;46(2):351-4. doi: 10.1007/s12020-013-0066-0. Epub 2013 Oct 4.

PMID:
24091542
44.

Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses.

Torino F, Barnabei A, Paragliola RM, Marchetti P, Salvatori R, Corsello SM.

Eur J Endocrinol. 2013 Oct 23;169(6):R153-64. doi: 10.1530/EJE-13-0434. Print 2013 Dec. Review.

PMID:
24001893
45.

Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer.

Torino F, Barnabei A, De Vecchis L, Sini V, Schittulli F, Marchetti P, Corsello SM.

Crit Rev Oncol Hematol. 2014 Jan;89(1):27-42. doi: 10.1016/j.critrevonc.2013.07.007. Epub 2013 Aug 13. Review.

PMID:
23953684
46.

Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).

Corsello SM, Salvatori R, Barnabei A, De Vecchis L, Marchetti P, Torino F.

Cancer Chemother Pharmacol. 2013 Aug;72(2):489-90. doi: 10.1007/s00280-013-2213-y. Epub 2013 Jun 19. No abstract available.

PMID:
23779068
47.

Thyroid dysfunction as an unintended side effect of anticancer drugs.

Torino F, Barnabei A, Paragliola R, Baldelli R, Appetecchia M, Corsello SM.

Thyroid. 2013 Nov;23(11):1345-66. doi: 10.1089/thy.2013.0241. Epub 2013 Sep 21. Review.

PMID:
23750887
48.

Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series.

Savino G, Balia L, Colucci D, Battendieri R, Gari M, Corsello SM, Pontecorvi A, Dickmann A.

Minerva Endocrinol. 2013 Jun;38(2):173-9.

PMID:
23732371
49.

Endocrine side effects induced by immune checkpoint inhibitors.

Corsello SM, Barnabei A, Marchetti P, De Vecchis L, Salvatori R, Torino F.

J Clin Endocrinol Metab. 2013 Apr;98(4):1361-75. doi: 10.1210/jc.2012-4075. Epub 2013 Mar 7. Review.

PMID:
23471977
50.

The first case of association between postpartum thyroiditis and thyroid hormone resistance in an Italian patient showing a novel p.V283A THRB mutation.

Paragliola RM, Concolino P, De Rosa A, Mello E, Zuppi C, Pontecorvi A, Capoluongo E, Corsello SM.

Thyroid. 2013 Apr;23(4):506-10. doi: 10.1089/thy.2012.0080. Epub 2013 Mar 18.

PMID:
23134553

Supplemental Content

Loading ...
Support Center